DEFT1P2

Across TCGA pan-cancer cohorts, DEFT1P2 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated DEFT1P2 data layer.

The strongest signal is observed in brain lower grade glioma (LGG), where higher DEFT1P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DEFT1P2 expression acts as an unfavorable survival marker.

LGG and BRCA are the cancer types where DEFT1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	DFS	Tertile	All	0.224	0.738	.013	18	view →
BRCA	OS	Tertile	All	0.181	0.579	.028	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

DEFT1P2–LGG (DFS)

Open the LGG breakdown →